The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on August 3, 2026

Aug. 3, 2026

EverQuote Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 3, 2026

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 3, 2026

Great Elm Capital Corp. (“GECC”) Schedules Second Quarter 2026 Earnings Release and Conference Call

Indeterminate GlobeNewswire

Aug. 3, 2026

Keros Therapeutics Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 3, 2026

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 3, 2026

Global Healthcare Fraud Detection Market to Reach $9.1 Billion by 2030, Driven by AI Adoption and Regulatory Pressure

Indeterminate GlobeNewswire

Aug. 3, 2026

Dan McGrath Named Chief Executive Officer of Harry Kahn Associates

Indeterminate GlobeNewswire

Aug. 3, 2026

Mimecast Unveils Agent Risk Center and Managed Threat Response at Black Hat 2026

Indeterminate GlobeNewswire

Aug. 3, 2026

Mercury Partners with Palantir to Enhance Factory Automation and Accelerate Production Timelines

Indeterminate GlobeNewswire

Aug. 3, 2026

Beacon Financial Corporation Appoints John B. Eagan General Counsel & Corporate Secretary

Indeterminate GlobeNewswire

Aug. 3, 2026

Cue Biopharma Announces Appointment of James M. Ahlers as Chief Financial Officer and CUE-221 Investigational New Drug Submission

Indeterminate GlobeNewswire

Aug. 3, 2026

Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026

Indeterminate GlobeNewswire

Aug. 3, 2026

Akebia Therapeutics Announces Initiation of a Phase 2 Basket Trial to Study Ebribafusp, a Next-Generation Complement Inhibitor in Rare Kidney Diseases

Indeterminate GlobeNewswire

Aug. 3, 2026

Schneider Electric releases pioneering study assessing arc flash risk in 800 VDC data centers aligning with world's leading hyperscalers

Indeterminate GlobeNewswire

Aug. 3, 2026

Curium Announces Definitive Agreement to Merge with Lantheus

Indeterminate GlobeNewswire

Aug. 3, 2026

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Aug. 3, 2026

Zevra Therapeutics Announces Publication of Four-Year Real-World Data from U.S. Early Access Program Evaluating MIPLYFFA® (arimoclomol) in Niemann-Pick Disease Type C (NPC)

Indeterminate GlobeNewswire

Aug. 3, 2026

PCI SSC Europe Community Meeting feiert 20-jähriges Jubiläum und kehrt nach Edinburgh zurück

Indeterminate GlobeNewswire

Aug. 3, 2026

Le PCI SSC Europe Community Meeting revient à Édimbourg pour célébrer son 20e anniversaire

Indeterminate GlobeNewswire

Aug. 3, 2026

Blancco Leaders to Speak at ITAD Summit on Building Smarter, More Efficient IT Asset Processing Operations

Indeterminate GlobeNewswire